Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes.
Berrou J, Fougeray S, Venot M, Chardiny V, Gautier JF, Dulphy N, Toubert A, Peraldi MN. PLoS One. 2013; 8(4):e62418. Epub 2013 Apr 25.